Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites

Virology

Volumn 386, Issue 1, 2009, Pages 32-43

  Bodaghi, Sohrab ^a   Jia, Rong ^a   Zheng, Zhi Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Human papillomavirus type 16; Protein protein interaction; RNA splicing; RNA protein interaction; SR proteins; Viral proteins

Indexed keywords

CYTOPLASM PROTEIN; GLYCOPROTEIN E2; HYBRID PROTEIN; ONCOPROTEIN; PROTEIN E6; REGULATOR PROTEIN; RNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN E6; VIRUS ENVELOPE PROTEIN E7;

AMINO TERMINAL SEQUENCE; ARTICLE; BOVINE PAPILLOMAVIRUS TYPE 1; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; ESCHERICHIA COLI; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INTRON; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RNA SPLICING; RNA TRANSCRIPTION;

DNA-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; REPRESSOR PROTEINS; RNA PRECURSORS; RNA SPLICING; RNA-BINDING PROTEINS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 61849173528     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.12.037     Document Type: Article

References (55)

1. Androphy E.J., Lowy D.R., and Schiller J.T. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325 (1987) 70-73
2. Antson A.A., Burns J.E., Moroz O.V., Scott D.J., Sanders C.M., Bronstein I.B., Dodson G.G., Wilson K.S., and Maitland N.J. Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 403 (2000) 805-809
3. Avvakumov N., Torchia J., and Mymryk J.S. Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Oncogene 22 (2003) 3833-3841
4. Bechtold V., Beard P., and Raj K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J. Virol. 77 (2003) 2021-2028
5. Bernat A., Avvakumov N., Mymryk J.S., and Banks L. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22 (2003) 7871-7881
6. Burd C.G., and Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science 265 (1994) 615-621
7. Davy C.E., Jackson D.J., Wang Q., Raj K., Masterson P.J., Fenner N.F., Southern S., Cuthill S., Millar J.B., and Doorbar J. Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J. Virol. 76 (2002) 9806-9818
8. Desaintes C., Hallez S., Van Alphen P., and Burny A. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66 (1992) 325-333
9. Doorbar J., Ely S., Sterling J., McLean C., and Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 352 (1991) 824-827
10. Doorbar J., Elston R.C., Napthine S., Raj K., Medcalf E., Jackson D., Coleman N., Griffin H.M., Masterson P., Stacey S., Mengistu Y., and Dunlop J. The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J. Virol. 74 (2000) 10081-10095
11. Frattini M.G., and Laimins L.A. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12398-12402
12. Graveley B.R. Sorting out the complexity of SR protein functions. RNA 6 (2000) 1197-1211
13. Hawley-Nelson P., Androphy E.J., Lowy D.R., and Schiller J.T. The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J. 7 (1988) 525-531
14. Hegde R.S. The papillomavirus E2 proteins: structure, function, and biology. Annu. Rev. Biophys. Biomol. Struct. 31 (2002) 343-360
15. Hegde R.S., and Androphy E.J. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J. Mol. Biol. 284 (1998) 1479-1489
16. Hou S.Y., Wu S.Y., Zhou T., Thomas M.C., and Chiang C.M. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex. Mol. Cell Biol. 20 (2000) 113-125
17. Huang S.M., and McCance D.J. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J. Virol. 76 (2002) 8710-8721
18. Hughes F.J., and Romanos M.A. E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res. 21 (1993) 5817-5823
19. Imai Y., Tsunokawa Y., Sugimura T., and Terada M. Purification and DNA-binding properties of human papillomavirus type 16 E6 protein expressed in Escherichia coli. Biochem. Biophys. Res. Commun. 164 (1989) 1402-1410
20. Kanda T., Watanabe S., Zanma S., Sato H., Furuno A., and Yoshiike K. Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif. Virology 185 (1991) 536-543
21. Kanopka A., Muhlemann O., and Akusjarvi G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381 (1996) 535-538
22. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., and Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A 94 (1997) 11612-11616
23. Klingelhutz A.J., Foster S.A., and McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380 (1996) 79-82
24. Kumar A., Zhao Y., Meng G., Zeng M., Srinivasan S., Delmolino L.M., Gao Q., Dimri G., Weber G.F., Wazer D.E., Band H., and Band V. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol. Cell Biol. 22 (2002) 5801-5812
25. LaCasse E.C., and Lefebvre Y.A. Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res. 23 (1995) 1647-1656
26. Ladd A.N., and Cooper T.A. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3 (2002) reviews0008
27. Lai M.C., Teh B.H., and Tarn W.Y. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J. Biol. Chem. 274 (1999) 11832-11841
28. Lee S.S., Weiss R.S., and Javier R.T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U. S. A 94 (1997) 6670-6675
29. Lowy D.R., and Howley P.M. Papillomaviruses. In: Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Straus S.E. (Eds). Fields Virology (2001), Lippincott Williams and Wilkins, Philadelphia 2231-2264
30. Maniatis T., and Reed R. An extensive network of coupling among gene expression machines. Nature 416 (2002) 499-506
31. Massimi P., Pim D., and Banks L. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. J. Gen. Virol. 78 (1997) 2607-2613
32. Nakahara T., Nishimura A., Tanaka M., Ueno T., Ishimoto A., and Sakai H. Modulation of the cell division cycle by human papillomavirus type 18 E4. J. Virol. 76 (2002) 10914-10920
33. Nomine Y., Charbonnier S., Ristriani T., Stier G., Masson M., Cavusoglu N., Van Dorsselaer A., Weiss E., Kieffer B., and Trave G. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain. Biochemistry 42 (2003) 4909-4917
34. Patel D., Huang S.M., Baglia L.A., and McCance D.J. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18 (1999) 5061-5072
35. Ristriani T., Masson M., Nomine Y., Laurent C., Lefevre J.F., Weiss E., and Trave G. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions. J. Mol. Biol. 296 (2000) 1189-1203
36. Ristriani T., Nomine Y., Masson M., Weiss E., and Trave G. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. J. Mol. Biol. 305 (2001) 729-739
37. Romanczuk H., Thierry F., and Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64 (1990) 2849-2859
38. Ronco L.V., Karpova A.Y., Vidal M., and Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12 (1998) 2061-2072
39. Sakai H., Yasugi T., Benson J.D., Dowhanick J.J., and Howley P.M. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 70 (1996) 1602-1611
40. Sousa R., Dostatni N., and Yaniv M. Control of papillomavirus gene expression. Biochim. Biophys. Acta 1032 (1990) 19-37
41. Tao M., Kruhlak M., Xia S., Androphy E., and Zheng Z.M. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J. Virol. 77 (2003) 13232-13247
42. Thain A., Webster K., Emery D., Clarke A.R., and Gaston K. DNA binding and bending by the human papillomavirus type 16 E2 protein. Recognition of an extended binding site. J. Biol. Chem. 272 (1997) 8236-8242
43. Thomas M.C., and Chiang C.M. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol. Cell 17 (2005) 251-264
44. Veldman T., Horikawa I., Barrett J.C., and Schlegel R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75 (2001) 4467-4472
45. Veldman T., Liu X., Yuan H., and Schlegel R. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci. U. S. A 100 (2003) 8211-8216
46. Zahler A.M., Neugebauer K.M., Stolk J.A., and Roth M.B. Human SR proteins and isolation of a cDNA encoding SRp75. Mol. Cell Biol. 13 (1993) 4023-4028
47. Zheng Z.M. Regulation of alternative RNA splicing by exon definition and exon sequences in viral and Mammalian gene expression. J. Biomed. Sci. 11 (2004) 278-294
48. Zheng Z.M., and Baker C.C. Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs. J. Virol. Methods 85 (2000) 203-214
49. Zheng Z.M., He P., and Baker C.C. Selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J. Virol. 70 (1996) 4691-4699
50. Zheng Z.M., He P.J., and Baker C.C. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers. J. Virol. 71 (1997) 9096-9107
51. Zheng Z.M., He P.J., and Baker C.C. Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3′ splice site. J. Virol. 73 (1999) 29-36
52. Zheng Z.M., Quintero J., Reid E.S., Gocke C., and Baker C.C. Optimization of a weak 3′ splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo. J. Virol. 74 (2000) 5902-5910
53. Zheng Z.M., Tao M., Yamanegi K., Bodaghi S., and Xiao W. Splicing of a cap-proximal human papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5′ cap. J. Mol. Biol. 337 (2004) 1091-1108
54. Zhou Z., Licklider L.J., Gygi S.P., and Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 419 (2002) 182-185
55. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350